Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes

Biochemistry

Volumn 44, Issue 24, 2005, Pages 8873-8882

  Rink, Rick ^a   Kuipers, Anneke ^a   De Boef, Esther ^a   Leenhouts, Kees J ^a   Driessen, Arnold J M ^b   Moll, Gert N ^a   Kuipers, Oscar P ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BACTERIA; BIOSYNTHESIS; DEHYDRATION; ENZYMES; HYDROPHOBICITY; MASS SPECTROMETRY; STATISTICAL METHODS;

LACTOCOCCUS LACTIS; LANTIBIOTICS; PEPTIDES; SERINE;

POLYPEPTIDES;

ACTAGARDIN; AMINO ACID; ANCOVENIN; BACTERIAL PROTEIN; CYSTEINE; DURAMYCIN; DURAMYCIN B; DURAMYCIN C; ENZYME; EPIDERMIN; ERICIN A; ERICIN S; GALLIDERMIN; HEXAPEPTIDE; HYBRID PROTEIN; LACTICIN 481; LANTHIONINE; LANTHIOPEPTIN; LANTIBIOTIC; MERSACIDIN; METHYL GROUP; MUTACIN 1140; MUTACIN B NY266; MUTACIN I; MUTACIN II; MUTACIN III; NISIN A; NISIN Q; NISIN Z; PLANTARICIDIN C; PROTEIN LTCA1; PROTEIN PLN W ALPHA; SA FF22; SALIVARICIN A; SERINE; SUBTILIN; THREONINE; UNCLASSIFIED DRUG; VARIACIN;

ARTICLE; COMPUTER MODEL; DRUG SYNTHESIS; ENZYME SPECIFICITY; HYDROPHILICITY; HYDROPHOBICITY; LACTOCOCCUS LACTIS; MASS SPECTROMETRY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROCESSING; SEQUENCE ANALYSIS;

ALANINE; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DNA PRIMERS; DRUG DESIGN; LACTOCOCCUS LACTIS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SULFIDES;

LACTOCOCCUS LACTIS;

EID: 20544436705     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050081h     Document Type: Article

References (74)

1. Ösapay, G., Prokai, L., Kim, H.-S., Medzihradszky, M. F., Coy, D. H., Liapakis, G., Reisine, T., Malacini, G., Zhu, Q., Wang, S. H. H., Mattern, R. H., and Goodman, M. (1997) Lanthionine-somatostatin analogs: synthesis, characterization, biological activity and enzymatic studies, J. Med. Chem. 40, 2241-2251.
2. Bierbaum, G., Szekat, C., Joste, M., Heidrich, C., Kempter, C., Jung, G., and Sahl, H.-G. (1996) Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5, Appl. Environ. Microbiol. 62, 385-392.
3. Van der Meer, J. R., Polman, J., Beerthuyzen, M. M., Siezen, R., Kuipers, O. P., and de Vos, W. M. (1993) Characterization of the Lactococcus lactis nisin A operon genes nisP, encoding a subtilin-like serine protease involved in precursor processing, and nisR, encoding a regulatory protein involved in nisin biosynthesis, J. Bacteriol. 175, 2578-2588.
4. Svensson, C. I., Rew, Y., Malkmus S., Schiller, P. W., Taulane J. P., Goodman, M., and Yaksh, T. L. (2003) Systemic and spinal analgesic activity of a δ-opioid-selective lanthionine enkephalin analog, J. Pharmacol. Exp. Ther. 304, 827-832.
5. Rew, Y., Malkmus, S., Svensson, C., Yaksh, T. L., Chung, N. N., Schiller, P. W., Cassel, J. A., DeHaven, R. N., and Goodman, M. (2002) Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands, J. Med. Chem. 45, 3746-3754.
6. Kohli, R. M., Trauger, J. W., Scharzer, D., Marahiel, M. A., and Walsh, C. T. (2001) Generality of peptide cyclization catalyzed by isolated thioesterase domains of nonribosomal peptide synthetases, Biochemistry 40, 7099-7108.
7. Kohli, R. M., Takagi, J., and Walsh, C. T. (2002) The thioesterase domain from a nonribosomal peptide synthetase as a cyclization catalyst for integrin binding peptides, Proc. Natl. Acad. Sci. U.S.A. 99, 1247-1252.
8. Destoumieux-Garzón, D., Peduzzi, J., and Rebuffat, S. (2002) Focus on modified microcins: structural features and mechanisms of action, Biochimie 84, 511-519.
9. Kemperman, R., Kuipers, A., Karsens, H., Nauta, A., Kuipers, O., and Kok, J. (2003) Identification and characterization of two novel clostridial bacteriocins, circularin A and closticin 574, Appl. Environ. Microbiol. 69, 1589-1597.
10. Gálvez, A., Giménez-Gallego, G., Maqueda, M., and Valdivia, E. (1989) Purification and amino acid composition of peptide antibiotic AS-48 produced by Streptococcus (Enterococcus) faecalis subsp. liquefaciens S-48, Antimicrob. Agents Chemother. 33, 437-441.
11. Xie, L., Miller, L. M., Chatterjee, C., Averin, O., Kelleher, N. L., and van der Donk, W. A. (2004) Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity, Science 303, 679-681.
12. Sahl, H.-G. (1991) Pore formation in bacterial membranes by cationic lantibiotics, in Nisin and novel lantibiotics (Jung, G., and Sahl, H.-G., Eds.) pp 347-358, Escom, Leiden.
13. Van Kraaij, C., de Vos, W. M., Siezen, R. J., and Kuipers, O. P. (1999) Lantibiotics: biosynthesis, mode of action and applications, Nat. Prod. Rep. 16, 575-587.
14. Bierbaum, G. (1999) Genetics of lantibiotic biosynthesis, in Ammo acids, peptides, porphyrins, alkaloids (Kelly, J. W., Ed.) Vol. 4, pp 275-301, Comprehensive Natural Products Chemistry (Barton, D., Nakanishi, K., and Meth-Cohn, O., Eds.), Elsevier, Amsterdam.
15. Kodani, S., Hudson, M. E., Durrant, M. C., Buttner, M. J., Nodwell, J. R., and Willey, J. M. (2004) The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor, Proc. Natl. Acad. Sci. U.S.A., 101, 11448-11453.
16. Okeley, N. M., Moushumi, P., Stasser, J. P., Blackburn, N., and van der Donk, W. A. (2003) SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins, Biochemistry 42, 13613-13624.
17. Bierbaum, G., and Sahl, H.-G. (1991) Induction of autolysis of Staphylococcus simulans 22 by Pep5 and nisin and influence of the cationic peptides on the activity of the autolytic enzymes, in Nisin and novel lantibiotics (Jung, G., and Sahl, H.-G., Eds.) pp 386-396, Escom, Leiden.
18. Gross, E., and Morrell, J. L. (1971) The structure of nisin, J. Am. Chem. Soc. 93, 4634-4635.
19. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O. P., Sahl, H.-G., arid de Kruijff, B. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic, Science 286, 2245-2247.
20. Kuipers, O. P., Yap, W. M. G. J., Rollema, H. S., Beerthuizen, M. M. Siezen, R. J., and de Vos, W. M. (1991) Expression of wild-type and mutant nisin genes in Lactococcus lactis, in Nisin and novel lantibiotics (Jung, G., and Sahl, H.-G., Eds.) pp 250-259, Escom, Leiden.
21. Kuipers, O. P., Bierbaum, G., Ottenwälder, B., Dodd, H. M., Horn, N., Metzger, J., Kupke, T., Gnau, V., Bongers, R., van den Boogaard, P., Kusters, H., Rollema, H. S., de Vos, W. M., Siezen, R. J., Jung, G., Götz, F., Sahl, H.-G., and Gasson, M. J. (1996) Protein engineering of lantibiotics, Antonie van Leeuwenhoek 69, 161-170.
22. Delves-Broughton, J., Blackburn, P., Evans, R. E., and Hugenholz, J. (1996) Applications of the bacteriocin, nisin, Antonie van Leeuwenhoek 69, 193-202.
23. Jung, G. (1991) Lantibiotics-ribosomally synthesized biologically active polypeptides sulfide bridges and α,β didehydroamine acids, Angew. Chem., Int. Ed. Engl. 30, 1051-1192.
24. Twomey, D., Ross, R. P., Ryan, M., Meany, B., and Hill, C. (2002) Lantibiotics produced by lactic acid bacteria: structure, function and applications, Antonie van Leeuwenhoek 82, 165-185.
25. Van de Kamp, M., van den Hooven, H. W., Konings, R. N. H., Hilbers, C. W., van de Ven, F. J. M., Bierbaum, G., Sahl, H.-G., Kuipers, O. P., Siezen, R. J., and de Vos, W. M. (1995a) Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermis K7-cloning of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7, Eur. J. Biochem. 230, 587-600.
26. Van de Kamp, M., Horstink, L. M., van den Hooven, H. W., Konings, R. N. H., Hilbers, C. W., Frey, A., Sahl, H.-G., Metzger, J. W., and van de Ven, F. J. M. (1995b) Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin-K7 from Staphylococcus epidermis K7, Eur. J. Biochem. 227, 757-771.
27. Kuipers, O. P., de Ruyter, P. G., Kleerebezem, M., and de Vos, W. M. (1997) Controlled overproduction of proteins by lactic acid bacteria, Trends Biotechnol. 15, 135-140.
28. Kuipers, A., De Boef, E., Rink, R., Fekken, S., Kluskens, L. D., Driessen, A. J. M., Leenhouts, K., Kuipers, O. P., and Moll, G. N. (2004) NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides, J. Biol. Chem. 279, 22176-22182.
29. Simon, D., and Chopin, A. (1988) Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis, Biochimie 70, 559-566.
30. Holo, H., and Nes, I. F. (1995) Transformation of Lactococcus by electroporation, Methods Mol. Biol. 47, 195-199.
31. Terzaghi, B. E., and Sandine, W. E. (1975) Improved medium for lactic streptococci and their bacteriophages, Appl. Microbiol. 29, 807-313.
32. Schägger, H., and von Jagow, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa, Anal. Biochem. 166, 368-379.
33. Novak, J., Kirk, M., Caufield, P. W., Barnes, S., Morrison, K., and Baker, J. (1996) Detection of modified amino acids in lantibiotic peptide mutacin II by chemical derivation and electrospray ionization-mass spectroscopic analysis, Anal. Biochem. 236, 358-360.
34. Allgaier, H., Jung, G., Werner, R. G., Schneider, U., and Zahner, H. (1986) Epidermin: sequencing a heterdet tetracyclic 21-peptide amide antibiotic, Eur. J. Biochem. 160, 9-22.
35. Freund, S., Jung, G., Gutbrod, O., Folkers, G., Gibbons, W. A., Allgaier, H., and Werner, R. (1991) The solution structure of the lantibiotic gallidermin, Biopolymers 31, 803-811.
36. Israil, A. M., Jack, R. W., Jung, G., and Sahl, H.-G. (1996) Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis- frequency of lantibiotic production in coagulase-negative staphylococci, Zentralbl. Bakteriol. 284, 285-296.
37. Smith, L., Novák, J., Rocca, J., McClung, S., Hillman, J. D., and Edison, A. S. (2000) Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics, Eur. J. Biochem. 267, 6810-1816.
38. Qi, F., Chen, P., and Caufield, P. W. (1999) Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analysis of mutacin III biosynthesis genes, Appl. Environ. Microbiol. 65, 3880-3887.
39. Mota-Meira, M., Lacroix, C., Lapointe, G., and Lavoie, M. C. (1997) Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans, FEBS Lett. 410, 275-279.
40. Qi, F., Chen, P., and Caufield, P. W. (2000) Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes, Appl. Environ. Microbiol. 66, 3221-3229.
41. Stein, T., Borchert, S., Conrad, B., Feesche, J., Hofemeister, B., Hofemeister, J., and Entian, K.-D. (2002) Two different lantibiotic-like peptides originate from the ericin gene cluster of Bacillus subtilis A1/3, J. Bacteriol. 184, 1703-1711.
42. Gross, E., Klitz, H. H., and Nebelin, E. (1973) Die struktur des subtilins, Hoppe-Seyler's Z. Physiol. Chem. 354, 819-812.
43. Mulders, J. W. M., Boerrigter, I. J., Rollema, H. S., Siezen, R. J., and de Vos, W. M. (1991) Identification and characterization of the lantibiotic nisin Z, a natural nisin variant, Eur. J. Biochem. 301, 581-584.
44. Zendo, T., Masanori, F., Ueda, K., Higuchi, T., Nakayama, J., and Sonomoto, K. (2003) Identification of the lantibiotic NisinQ, a new natural nisin variant produced by Lactococcus lactis 61-64 isolated from a river in Japan, Biosci., Biotechnol. Biochem. 67, 1616-1619.
45. Zimmermann, N., Freund, S., Fredenhagen, A., and Jung, G. (1993) Solution structures of the lantibiotics duramycin B and C, Eur. J. Biochem. 216, 419-428.
46. Bierbaum, G., Brötz, H., Koller, K.-P., and Sahl, H.-G. (1995) Cloning sequencing and production of the lantibiotic mersacidin, FEMS Microbiol. Lett. 127, 121-126.
47. Prasch, T., Naumann, T., Market, R. L. M., Sattler, M., Schubert, W., Schaal, S., Bauch, M., Kogler, H., and Griesinger, C. (1997) Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics, Eur. J. Biochem. 244, 501-512.
48. Turner, D. L., Brennan, L., Meyer, H. E., Lohaus, C., Siethoff, C., Costa, H. S., Consalez, B., Santos, H., and Suarez, J. E. (1999) Solution structure of plantaricin C, a novel lantibiotic, Eur. J. Biochem. 264, 833-839.
49. Ross, K. F., Ronson, C. W., and Tagg, J. R. (1993) Isolation and characterization of the lantibiotic salivaricin A and its structural gene sa1A from Streptococcus salivarius 20P3, Appl. Environ. Microbiol. 59, 2014-2021.
50. Pridmore, D., Rekhif, N., Pittet, A. C., Suri, B., and Mollet, B. (1996) Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: Comparison to lacticin 481 of Lactococcus lactis, Appl. Environ. Microbiol. 62, 1799-1802.
51. Van den Hooven, H. W., Lagerwerf, F. M., Heerma, W., Haverkamp, J., Piard, J.-C., Hilbers, C. W., Siezen, R. J., Kuipers, O. P., and Rollema, H. S. (1996) The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges, FEBS Lett. 391, 317-322.
52. Krull, R. E., Chen, P., Novák, J., Kirk, M., Barnes, S., Baker, J., Krishna, N. R., and Caufield, P. W. (2000) Biochemical structural analysis of the lantibiotic mutacin II, J. Biol. Chem. 275, 15845-15850.
53. Jack, R. W., Carne, A., Metzger, J., Stefanovic, S., Sahl, H.-G., Jung, G., and Tagg, J. (1994) Elucidation of the structure of SA-FF22 lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22, Eur. J. Biochem. 220, 455-462.
54. Martin, N. I., Sprules, T., Carpenter, M. R., Cotter, P. D., Hill, C., Ross, R. P., and Vederas, J. C. (2004) Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity, Biochemistry 43, 3049-3056.
55. Holo, H., Jeknic, Z., Daeschel, M., Stevanovic, S., and Nes, I. F. (2001) Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics, Microbiology 147, 643-651.
56. 13C NMR assignments and revised primary structure, Eur. J. Biochem. 228, 786-797.
57. Kessler, H., Steuernagel, S., Will, M., Jung, G., Kellner, R., Gillessen, D., and Kamiyami, T. (1988) The structure of the polycyclic nonadecapeptide Ro 09-0198, Helv. Chim. Acta 71, 1924-1929.
58. Paik, S. H., Chakicheria, A., and Hansen, J. N. (1998) Identification and characterization of the structural and transporter genes for and the chemical and biological properties of sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168, J. Biol. Chem. 273, 23134-23142.
59. Kellner, R., Jung, G., Kaletta, C., Entian, K.-D., and Sahl, H.-G. (1989) Pep5: structure elucidation of a large lantbiotic, Angew. Chem., Int. Ed. Engl. 28, 616-619.
60. Heidrich, C., Pag, U., Josten, M., Metzger, J., Jack, R. W., Bierbaum, G., Jung, G., and Sahl, H.-G. (1998) Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analyis of its biosynthetic gene cluster, Appl. Environ. Microbiol. 64, 3140-3146.
61. Skaugen, M. (1994) Lactocin S: structure determination and genetic analysis, Doctoral Thesis, Agricultural University of Norway, Ås, Norway.
62. Minami, Y., Yoshida, K.-I., Azuma, R., Urakawa, A., Kawauchi, T., Otani, T., Komiyama, K., and Omura, S. (1994) Structure of cypemycin, a new peptide antibiotic, Tetrahedron Lett. 35, 80001-8004.
63. Karakas, S. A., Narbad, A., Horn, N., Dodd, H. M., Parr, A. J., Colquhoun, I., and Gasson, M. J. (1999) Posttranslational modification of nisin. The involvement of NisB in the dehydration process, Eur. J. Biochem. 261, 524-532.
64. Zhou, H., and van der Donk, W. A. (2002) Biomimetic stereoselective formation of methyllanthionine, Org. Lett. 4, 1335-1338.
65. Okeley, N. M., Zhu, Y., and van der Donk, W. A. (2000) Facile chemoselective synthesis of dehydroalanine-containing peptides, Org. Lett. 2, 3603-3606.
66. Burrage, S., Raynham, T., Williams, G., Essex, J. W., Allen, C., Carno, M., Swali, V., and Bradley, M. (2000) Biomimetic synthesis of lantibiotics, Chem. Eur. J. 6, 1455-1466.
67. Zhu, Y., Matt, D., Zhou, H., Averin, O., and van der Donk, W. A. (2003) Biomimetic studies on the mechanism of stereoselective lathionine formation, Org. Biomol. Chem. 1, 3304-3315.
68. Moll, G. N., Roberts, G. C. K., Konings, W. N., and Driessen, A. J. M. (1996) Bacteriocins: mechanism of membrane insertion and pore formation, Antonie van Leeuwenhoek. 69, 185 -191.
69. Van Kraaij, C., Breukink, E., Rollema, H. S., Bongers, R. S., Kosters, H. A., de Kruijff, B., and Kuipers, O. P. (2000) Engineering a disulfide bond and free thiols in the lantibiotic nisin Z, Eur. J. Biochem. 267, 901-909.
70. Kuipers, O. P., Rollema, H. S., Yap, W. M. G. J., Boot, H. J., Siezen, R. J., and de Vos, W. M. (1992) Engineering dehydrated amino acid residues in the antimicrobial peptide nisin, J. Biol. Chem. 267, 24340-24346.
71. Van Kraaij, C., Breukink, E., Rollema, H. S., Siezen, R. J., Demel, R. A., De Kruijff, B., and Kuipers, O. P. (1997) Influence of charge differences in the C-terminal part of nisin on antimicrobial activity and signaling capacity, Eur. J. Biochem. 247, 114-120.
72. Breukink, E., van Kraaij, C., Demel, R. A., Siezen, R. J., Kuipers, O. P., and de Kruijff, B. (1997) The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane, Biochemistry 36, 6968-6976.
73. Schnell, N., Entian, K.-D., Götz, F., Hörner, T., Kellner, R., and Jung, G. (1989) Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic, FEMS Microbiol. Lett. 58, 263-268.
74. Chen, P., Novak, J., Kirk, M., Barnes, S., Qi, F., and Caufield, P. W. (1998) Structure-activity study of the lantibiotic mutacinII from Streptococcus mutans T8 by a gene replacement strategy, Appl. Environ. Microbiol. 64, 2335-2340.